PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
RVMD vs. ROAD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between RVMD and ROAD is 0.26, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.3

Performance

RVMD vs. ROAD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Revolution Medicines, Inc. (RVMD) and Construction Partners, Inc. (ROAD). The values are adjusted to include any dividend payments, if applicable.

-20.00%0.00%20.00%40.00%60.00%SeptemberOctoberNovemberDecember2025February
-5.27%
13.05%
RVMD
ROAD

Key characteristics

Sharpe Ratio

RVMD:

1.00

ROAD:

1.34

Sortino Ratio

RVMD:

1.59

ROAD:

1.94

Omega Ratio

RVMD:

1.19

ROAD:

1.25

Calmar Ratio

RVMD:

0.89

ROAD:

2.13

Martin Ratio

RVMD:

2.89

ROAD:

6.46

Ulcer Index

RVMD:

14.45%

ROAD:

9.28%

Daily Std Dev

RVMD:

41.82%

ROAD:

44.86%

Max Drawdown

RVMD:

-73.29%

ROAD:

-54.54%

Current Drawdown

RVMD:

-31.78%

ROAD:

-28.22%

Fundamentals

Market Cap

RVMD:

$7.82B

ROAD:

$4.44B

EPS

RVMD:

-$3.66

ROAD:

$1.06

Total Revenue (TTM)

RVMD:

$0.00

ROAD:

$1.99B

Gross Profit (TTM)

RVMD:

-$130.80M

ROAD:

$282.96M

EBITDA (TTM)

RVMD:

-$470.00M

ROAD:

$157.36M

Returns By Period

In the year-to-date period, RVMD achieves a -5.49% return, which is significantly higher than ROAD's -17.35% return.


RVMD

YTD

-5.49%

1M

1.03%

6M

-5.27%

1Y

42.31%

5Y*

6.34%

10Y*

N/A

ROAD

YTD

-17.35%

1M

-21.20%

6M

13.05%

1Y

57.16%

5Y*

33.06%

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

RVMD vs. ROAD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

RVMD
The Risk-Adjusted Performance Rank of RVMD is 7474
Overall Rank
The Sharpe Ratio Rank of RVMD is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of RVMD is 7373
Sortino Ratio Rank
The Omega Ratio Rank of RVMD is 6969
Omega Ratio Rank
The Calmar Ratio Rank of RVMD is 7777
Calmar Ratio Rank
The Martin Ratio Rank of RVMD is 7272
Martin Ratio Rank

ROAD
The Risk-Adjusted Performance Rank of ROAD is 8484
Overall Rank
The Sharpe Ratio Rank of ROAD is 8585
Sharpe Ratio Rank
The Sortino Ratio Rank of ROAD is 7979
Sortino Ratio Rank
The Omega Ratio Rank of ROAD is 7878
Omega Ratio Rank
The Calmar Ratio Rank of ROAD is 9191
Calmar Ratio Rank
The Martin Ratio Rank of ROAD is 8585
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

RVMD vs. ROAD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Revolution Medicines, Inc. (RVMD) and Construction Partners, Inc. (ROAD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for RVMD, currently valued at 1.00, compared to the broader market-2.000.002.001.001.34
The chart of Sortino ratio for RVMD, currently valued at 1.59, compared to the broader market-4.00-2.000.002.004.006.001.591.94
The chart of Omega ratio for RVMD, currently valued at 1.19, compared to the broader market0.501.001.502.001.191.25
The chart of Calmar ratio for RVMD, currently valued at 0.89, compared to the broader market0.002.004.006.000.892.13
The chart of Martin ratio for RVMD, currently valued at 2.89, compared to the broader market-10.000.0010.0020.0030.002.896.46
RVMD
ROAD

The current RVMD Sharpe Ratio is 1.00, which is comparable to the ROAD Sharpe Ratio of 1.34. The chart below compares the historical Sharpe Ratios of RVMD and ROAD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025February
1.00
1.34
RVMD
ROAD

Dividends

RVMD vs. ROAD - Dividend Comparison

Neither RVMD nor ROAD has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

RVMD vs. ROAD - Drawdown Comparison

The maximum RVMD drawdown since its inception was -73.29%, which is greater than ROAD's maximum drawdown of -54.54%. Use the drawdown chart below to compare losses from any high point for RVMD and ROAD. For additional features, visit the drawdowns tool.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-31.78%
-28.22%
RVMD
ROAD

Volatility

RVMD vs. ROAD - Volatility Comparison

The current volatility for Revolution Medicines, Inc. (RVMD) is 9.50%, while Construction Partners, Inc. (ROAD) has a volatility of 16.90%. This indicates that RVMD experiences smaller price fluctuations and is considered to be less risky than ROAD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


8.00%10.00%12.00%14.00%16.00%18.00%20.00%SeptemberOctoberNovemberDecember2025February
9.50%
16.90%
RVMD
ROAD

Financials

RVMD vs. ROAD - Financials Comparison

This section allows you to compare key financial metrics between Revolution Medicines, Inc. and Construction Partners, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab